BILIX
Live / Registered — Registered (as of 06 Sept 2022)
What this means for you
Registered since 06 Sept 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79302549
- Registration number
- 6835721
- Mark type
- Stylized text
- Filed
- 11 Nov 2020
- Published for opposition
- 21 Jun 2022
- Registered
- 06 Sept 2022
- Attorney of record
- James R Menker
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for neurological disease; pharmaceutical preparations for inflammatory diseases; pharmaceutical preparations for ocular and intraocular surgery; pharmaceutical preparations for rare autoimmune diseases in the nature of autoimmune lymphoproliferative syndrome, lupus, and multiple sclerosis; pharmaceutical products for the treatment of rare autoimmune diseases and disorders; pharmaceutical products for the prevention and treatment of rare genetic diseases affecting red blood cells; medicated ointments for treating dermatological conditions; antibiotic ointments; mentholated ointment for medical use; anti-inflammatory ointments; chemical reagents for purposes of medical diagnosis; diagnostic preparations for diagnosing inflammatory diseases; diagnostic radiopharmaceutical preparations; pharmaceutical and biological preparations for use in diagnosis, namely, for use as ultrasound and x-ray contrast reagents; antibiotics; anti-inflammatory preparations; anti-cancer preparations; biological preparations for the treatment of cancer; cardiovascular pharmaceutical preparations; dermatological pharmaceutical products; diagnostic preparations for medical or veterinary purposes; genetic identity tests comprised of reagents for medical purposes; human vaccine preparations; medicines for dental purposes; medicines for intestinal disorders; ophthalmic preparations; pharmaceutical agents affecting digestive organs; pharmaceutical agents affecting metabolism; pharmaceutical agents affecting peripheral nervous system; pharmaceutical agents affecting sensory organs; pharmaceutical preparations acting on the central nervous system; pharmaceutical agents for epidermis; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; pharmaceutical preparations for peripheral nervous system; pharmaceutical preparations for the treatment of hormonal disorders; pharmaceutical preparations for the treatment of hypercholesteremia; pharmaceutical preparations for the treatment of hyperlipidemia; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for the treatment of musculo-skeletal disorders; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for treating hypertension; pharmaceutical preparations for treating skin disorders; pharmaceutical products for the treatment of cancer; pharmaceutical products for the treatment of infectious diseases; pharmaceutical products for the treatment of viral diseases; pharmaceutical products for treating respiratory diseases; pharmaceuticals for the treatment of erectile dysfunction; preparations for the treatment of asthma; tumor suppressing agents; vaccines; immunoassay reagents for medical use
- Class 042 — Scientific and technological services: Pharmaceutical research services; drug discovery services; medical research; pharmaceutical product evaluation; scientific investigations for medical purposes; scientific research for medical purposes in the area of cancerous diseases; development of pharmaceutical preparations and medicines; consulting on the testing, inspection and research of medical products for quality control purposes; providing information on the testing, inspection and research of medical products for quality control purposes; industrial research in the fields of medicine, health and pharmacology; engineering services in the medical technology field
Owner
- Bilix Co., Ltd., KR
- Bilix Co., Ltd., KR
- Bilix Co., Ltd., KR
Prosecution history
- 03 Jan 2023 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 09 Dec 2022 — FINAL DISPOSITION NOTICE SENT TO IB
- 09 Dec 2022 — FINAL DISPOSITION PROCESSED
- 06 Dec 2022 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 06 Sept 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 06 Sept 2022 — REGISTERED-PRINCIPAL REGISTER
- 11 Jul 2022 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 05 Jul 2022 — NOTIFICATION PROCESSED BY IB
- 22 Jun 2022 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 22 Jun 2022 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 21 Jun 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 21 Jun 2022 — PUBLISHED FOR OPPOSITION
- 08 Jun 2022 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 08 Jun 2022 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 01 Jun 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED